A UK medical cannabis clinics group has supported more than 1,500 patients to access treatment in 2020.
The Medical Cannabis Clinics (TMCC) has revealed it recently reached the significant milestone of consulting and prescribing for over 1,500 patients in the last 12 months.
This works out at 60 percent of an estimated total of 2,500 cannabis patients in the UK, for which pharmacy Dispensary Green, owned by LYPHE Group, fulfills almost all medications.
At the end of 2019, despite the change in legislation to allow for medical cannabis prescriptions being then a year old, only a few dozen patients had been able to access treatment.
Despite the challenges of the pandemic, the milestone represents a “dramatic improvement” in the state of care in the UK, according to TMCC – with predictions of up to 15,000 patients in the UK by the end of 2021.
While there is still more to be done in creating a deeper evidence base for wider access broader to medical cannabis, TMCC, which is led by a team of twenty-five prescribing specialist doctors, is hoping for another year of “exponential growth”, and “expanded and improved care” in 2021.
“Everyone at TMCC is delighted to have made this much progress in 2020,” said TMCC medical director, Dr Sunny Nayee.
“From almost a standing start in the previous year, we’re now providing patient care to many who need it. This is a great foundation on which to grow, and that means helping even more patients still.”
TMCC provided a snapshot of medical cannabis patients in the UK, revealing that almost three quarters of patients are aged between 25 and 54.
Around 40 percent of patients are based in London and half are receiving treatments for chronic pain conditions, with 24 percent using medical cannabis for mental health conditions such as anxiety, depression and PTSD and only three percent of patients receiving medical cannabis primarily for the management of intractable childhood epilepsy.
Who is accessing medical cannabis treatment?
- Demographics of treatments are revealing, with 73 percent of prescriptions being written for patients between the ages of 25 and 54.
- Only 11 percent of prescriptions have been written for patients aged 24 or under, of which only 4 percent are written for patients 17 or under, reflecting the greater degree of caution and scrutiny in prescribing for younger patients.
- Considering the substantial clinical potential of medical cannabis in managing later life ailments, there is still clearly work to be done in opening up treatments to elderly categories, with only 15 percent of prescriptions being written for patients over the age of 55.
- Further evidence to support the use of CBMPs for relevant conditions, as well as more education to remove prevalent misconceptions of medical cannabis in older age groups, will likely improve this picture.
- The gender distribution of patients is predominantly male (66 percent) over female (34 percent).
Where are patients from?
- London remains the main centre of activity in the UK with around 40 percent of patients coming from this area.
- Birmingham, Manchester and Bristol account for 22 percent of other patient activity and Leeds, Nottingham and Liverpool a further 12 percent, with the remaining quarter of consultations distributed outside of urban areas throughout the country.
What conditions are most commonly being treated?
- Reflecting one of the primary areas of interest in and application for medical cannabis, around 50 percent of patients are receiving treatments for chronic pain conditions. These are often conditions like lower back pain, arthritic pain or pain relating to conditions like MS.
- A further 24 percent of patients are receiving medical cannabis care for psychiatric conditions. Often used as an adjunct to psychiatric care, treated conditions range from PTSD to anxiety and depression.
- Adult neurology represents around 11 percent of TMCC care to date, and these prescriptions are usually written for the management of symptoms relating to MS and other movement disorders.
- Complex care patients, such as those in palliative care or those needing combined clinical support to treat difficult conditions, represent six percent of patients.
- Gastroenterology conditions make up three percent of prescriptions, for conditions such as Crohn’s or IBS. This proportion is the same for oncology patients, where medical cannabis can be prescribed to manage chemotherapy-induced nausea and vomiting (CINV)
- Paediatric neurology patients complete the picture, with around three percent of patients receiving medical cannabis care primarily for the management of intractable childhood epilepsy.
The Medical Cannabis Clinics is a telemedicine clinic specialising in innovative cannabis-based medical therapies. For more information visit themedicalcannabisclinics.com
The best ways to take CBD for pain relief
CBD is becoming a popular tool for pain management, but with so many options out there, how do you know where to start?
With research constantly emerging to support the health benefits of CBD, more and more people are turning to the remedy – especially when it comes to alleviating pain and discomfort.
But how does it actually work? There are several ways to take CBD, each offering various pros and cons – we’ve rounded up some of the best methods.
In terms of pain relief, one of the most common methods is on the skin. Topical products like lotions and balms can be applied to skin over painful joints or bones and are particularly effective when used to relieve symptoms of arthritis.
However, research is still ongoing to determine whether these products deliver CBD below the skin. It is also difficult to pinpoint the exact effect CBD delivers – with many including common over-the-counter ingredients such as menthol, capsaicin and camphor, it’s uncertain whether the positive relief is solely due to CBD, or if these other ingredients play a significant role.
Several studies have hailed CBD oil as one of the most helpful methods when it comes to relieving pain symptoms, especially when combined with other forms such as topicals.
Medical nutritionist and health author Dr Sarah Brewer said: “Cannabidiol oil has direct effects on the endocannabinoid system in the brain. This enhances the effects of other brain chemicals, such as serotonin and anandamide, to reduce pain perception. It is also a powerful antioxidant which suppresses inflammation.”
Something to digest
Another well-known method for using CBD is by mouth. Whether in capsules, food or liquid, CBD that is swallowed is absorbed through the digestive tract.
Despite its popularity, this method does have its downfalls. Absorption is slow and dosing can be tricky due to the delayed onset of effect (it can take one to two hours to fully have an impact), plus many believe there isn’t enough research into how recent meals and other factors affect consumption.
But it has been widely reported that after a safe and effective dose has been established, capsules can work for daily use.
While it may not taste particularly pleasant, CBD can also be effectively absorbed directly into the bloodstream by holding liquid from a spray or dropper under the tongue. Research shows effects can the be felt in as little as a few minutes.
Give the vapors
CBD can also be inhaled via a vaporising, ‘vape’ pen. However, it’s possible that inhalation can carry unknown risks, particularly in those with respiratory issues and ailments such as inflammatory arthritis, and so isn’t widely recommended as a method for use.
With all methods, the common downfall is wavering dosage guidelines. Measures can change depending on a number of factors including age, weight and reason for use, however resounding guidance from experts is to ‘go low and slow’. Start with just a few milligrams twice a day, and if relief is inadequate after one week, increase the dose by the same amount, in small increments over several weeks if needed.
It’s clear that more research is needed to determine exact details into these methods, but this is only set to increase as the number of people turning to CBD for pain relief continues to grow.
CBD distillates, isolates & full spectrum – what’s the difference?
With so many CBD products on the market, do you know your distillates from your isolates? The experts at US manufacturer Fresh Bros break it down.
Las Vegas manufacturer Fresh Bros have nearly a decade of experience in the hemp industry.
But with so many products on the market Fresh Bros want to help consumers find the best products for their needs.
Here they explain the differences between CBD distillate, CBD isolate, and full-spectrum CBD products, as well as highlighting the key differences between Delta 8 THC and Delta 9 THC.
Cannabidiol (CBD) is one of the most researched compounds of all the known phytocannabinoids found in the cannabis plant.
CBD isolates are, unsurprisingly, isolated forms of CBD. During the extraction process, cannabidiols are removed or filtered out of the hemp plant except for CBD, resulting in a pure product.
CBD isolate is great for anyone who struggles with the original earthy flavors of other conventional oils or edibles, so if you’d prefer a high-potency CBD product that is tasty, doesn’t contain THC and or any “extra” cannabinoids that are found in a distillate or full-spectrum product — CBD isolate may be the way to go.
Unlike CBD isolate, CBD distillate (aka broad-spectrum CBD) typically contains an array of cannabinoids, terpenes, vitamins, and fatty acids that are very beneficial to the body. CBD distillate contains only negligible amounts of THC after going through special processing.
CBD isolate is an incredible healing source, of course, but there are hundreds of other beneficial cannabinoids found in the hemp plant besides CBD – cannabinol (CBN) and cannabigerol (CBG) to name a couple.
Therefore, if you want to reap all of the potential benefits of CBD without the high, and you don’t mind the stronger taste, CBD distillate may be the best option for you.
Full-spectrum CBD products contain all cannabinoids, terpenes, and plant materials – including the naturally occurring small amount of THC in hemp.
Delta 8 THC vs Delta 9 THC
The cannabis plant has more than 120 cannabinoids, but only a fraction of these have really been studied and marketed. Delta 9 THC is the psychoactive compound found in cannabis, and has received a lot of attention over the last few years.
However, consumers are slowly noticing the lesser-known Delta 8 THC (a less available double-bond isomer of the more common Delta 9 THC, also derived from hemp) due to its unique properties. The main differences between these two types of THC are found in the molecular structures of both, and it’s worth noting that Delta 8 THC is capable of producing a milder, more manageable, and more enjoyable high compared to Delta 9.
Delta 8 also has added therapeutic benefits and less severe and functionality-impairing side effects.
Five ways CBD can help you cope with anxiety
With at least half of the population experiencing some anxiety since the beginning of the coronavirus pandemic, it’s hardly surprising sales of CBD have soared. This is what the research says.
Anxiety is one of the most common mental health disorders, with an estimated four per cent of the population suffering from some form of the condition.
With global issues such as the Covid-19 pandemic causing the number of people with anxiety to continue to rise, many are left searching for solutions – so, could CBD be the key to alleviating symptoms?
Although more research is needed in the area, a 2019 Gallup poll found that 37 per cent of CBD users take the supplement to relieve anxiety. Here are five ways it could help…
While low serotonin levels are generally linked with depression, there is evidence to show it could also be a cause of anxiety. In conventional mental health care, cases of low serotonin are treated with a category of anti-depressant medications known as selective serotonin reuptake inhibitors, such as fluoxetine (Prozac).
However, CBD may have the potential to change serotonin signals in the body through the interaction with CB1, a receptor found in the central nervous system, meaning it can ‘boost’ your overall mood by changing the way your body reacts to serotonin.
Anxiety and trouble sleeping have been linked for years, but recent studies have found that CBD could be a solution to both issues.
Research published in 2019 looked at whether CBD could improve sleep and reduce anxiety. The study involved 72 subjects experiencing anxiety and/or poor sleep. In the first month, 79.2 per cent of patients reported lower anxiety levels and 66.7 per cent reported better sleep.
While research into this area is still ongoing, preliminary studies from the National Institute on Drug Abuse suggest that CBD has been shown to reduce stress in animals such as rates.
Study subjects were observed as having lower behavioural signs of anxiety, and physiological symptoms of anxiety, such as increased heart rate, also improved.
Help with relaxation
Tetrahydrocannabinol (THC) is the main psychoactive cannabinoid found in cannabis and causes the sensation of getting “high” that’s often associated with marijuana. CBD, however, will not get you high, but may offer similar feelings when it comes to relaxation.
While THC activates CB1 receptors that are associated with euphoria, CBD is a CB1 antagonist and will block or modulate THC’s intoxicating effects. This has led many to believe that CBD is a good way to decrease the negative side effects of THC, such as anxiety, and help you relax and de-stress without feeling high.
Improve quality of life
In a 2020 study, researchers evaluated CBD’s effects in 397 adults living in New Zealand, with study participants receiving medical CBD prescriptions for a variety of ailments, including mental health symptoms.
All groups reported improvements in their overall quality of life after 3 weeks of CBD treatment. The individuals who received CBD treatment for anxiety or depression reportedly experienced improvements in their ability to perform daily functions and reduce pain and anxiety or depression symptoms.
Around 70 per cent of study participants reported some level of satisfaction with CBD treatment, ranging from good to excellent.
- Study finds ‘one in four’ started using CBD during COVID-19
- “This is not compassionate”: Ireland’s medical cannabis scheme ‘excludes thousands of patients’
- Vitality CBD ‘leading the way’ with novel food application
- Can CBD improve your mood?
- “Huge relief” as threat to children’s medical cannabis is resolved
- CBD shown to kill antibiotic resistant bacteria – study
News6 months ago
NHS lines up cannabis medicine manufacturing
News2 months ago
Community extends support to cannabis icon Rick Simpson
Case Studies10 months ago
CBD oil and fibromyalgia – a case study
Feature7 months ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt
Insight3 months ago
I’ve gone from a wheelchair to walking thanks to cannabis
News4 months ago
“I’m not a bad person” – chronically ill woman convicted of growing medical cannabis
News4 months ago
Cancer survivor claims cannabis oil helped her beat brain tumour
News4 months ago
Mum of three-year-old with ‘one in a million’ condition fights for medical cannabis funding